Generation of tumor-specific T lymphocytes by cross-priming with human dendritic cells ingesting apoptotic tumor cells

Cancer Research

Volumn 60, Issue 13, 2000, Pages 3542-3549

  Hoffmann, Thomas K ^a   Meidenbauer, Norbert ^a   Dworacki, Grzegorz ^a   Kanaya, Hiroaki ^a   Whiteside, Theresa L ^a,b  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON;

ANTIGEN PRESENTATION; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL MATURATION; CYTOTOXICITY; DENDRITIC CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; T LYMPHOCYTE;

ANTIGENS, CD; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTORS, RECOMBINANT; HEAD AND NECK NEOPLASMS; HLA-A2 ANTIGEN; HUMANS; INTERFERON TYPE II; INTERLEUKIN-4; K562 CELLS; RECOMBINANT PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0034235599     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Bevan M. J. Cross-priming for a secondary cytotoxic response to minor H antigen with H-2 congenic cells which do not cross-react in the cytotoxic assay. J. Exp. Med., 143: 1283-1288, 1976.
2. Huang, A. Y. C., Golumbek, P., Ahmadzadeh, M., Jaffee, E., Pardoll, D., and Levitsky, H. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science (Washington DC), 264: 961-965, 1994.
3. Paglia, P., Chiodoni, C., Rodolfo, M., and Colombo, M. P. Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo. J. Exp. Med., 183: 317-322, 1995.
4. Reis e Sousa, C., and Germain, R. N. Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis. J. Exp. Med., 182: 841-851, 1995.
5. Norbury, C. C., Chambers, B. J., Prescott, A. R., Ljunggren, H. G., and Watts, C. Constitutive macropinocytosis allows TAP-dependent presentation of exogenous antigen on class I MHC molecules by bone marrow derived dendritic cells. Eur. J. Immunol., 27: 280-288, 1997.
6. Rosenberg, S. A. A new era for cancer immunotherapy based on genes that encode cancer antigens. Immunity, 10: 281-287, 1999.
7. Albert, M. L., Sauter, B., and Bhardwaj, N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTL. Nature (Lond.), 392: 86-89, 1998.
8. 5 and CD36, and cross present antigens to cytotoxic T lymphocytes. J. Exp. Med., 188: 1359-1368, 1998.
9. Bellone, M. G., Iezzi, G., Rovere, P., Galati, G., Ronchetti, A., Protti, M. P., Davoust, J., Rugarli, C., and Manfredi, A. A. Processing of engulfed apoptotic bodies yields T cell epitopes. J. Immunol., 159: 5391-5399, 1997.
10. Rovere, P., Vallinoto, C., Bondanza, A., Crosti, M. C., Rescigno, M., Ricciardi-Castagnoli, P., Rugarli, C., and Manfredi, A. A. Bystander apoptosis triggers dendritic cell maturation and antigen-presenting function. J. Immunol., 161: 4467-4471, 1998.
11. Henry, F., Boisteau, O., Bretaudeau, L., Lieubeau, B., Meflah, K., and Grégoire, M. Antigen-presenting cells that phagocytose apoptotic tumor-derived cells are potent tumor vaccines. Cancer Res., 59: 3329-3332, 1999.
12. Ronchetti, A., Rovere, P., Iezzi, G., Galati, G., Heltai, S., Protti, M. P., Grarancini, M. P., Manfredi, A. A., Rugarli, C., and Bellone, M. G. Immunogenicity of apoptotic cell in vivo: role of antigen load, antigen-presenting cells, and cytokines. J. Immunol., 161: 130-136, 1999.
13. Heo, D. S., Snyderman, C., Gollin, S. M., Pan, S., Walker, P., Deka, R., Barnes, E. L., Herberman, R. B., and Whiteside, T. L. Biology, cytogenetics, and sensitivity to immunological effector cells of new head and neck squamous cell carcinoma lines. Cancer Res., 49: 5167-5175, 1989.
14. Sallusto, F., and Lanzavecchia, A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin-4 and down-regulated by tumor necrosis factor alpha. J. Exp. Med., 179: 1109-1118, 1994.
15. Yasumura, S., Hirabayashi, H., Schwartz, D. R., Toso, J. F., Johnson, J. T., Herberman, R. B., and Whiteside, T. L. Human cytotoxic T cell lines with restricted specificity for squamous cell carcinoma of the head and neck. Cancer Res., 53: 1461-1468, 1993.
16. Yasumura, S., Weidmann, E., Hirabayashi, H., Johnson, J. T., Herberman, R. B., and Whiteside, T. L. HLA restriction and T cell-receptor V β gene expression of cytotoxic T lymphocytes reactive with human squamous-cell carcinoma of the head and neck. Int. J. Cancer, 57: 297-305, 1994.
17. Saito, T., Kuss, I., Dworacki, G., Gooding, W., Johnson, J. T., and Whiteside, T. L. Spontanous ex vivo apoptosis of peripheral blood mononuclear cells in patients with head and neck cancer. Clin. Cancer Res., 5: 1263-1273, 1999.
18. Bedner, E., Li, X., Gorczyca, W., Melamed, M. R., and Darzynkiewicz, Z. Analysis of apoptosis by laser scanning cytometry. Cytometry, 35: 181-195, 1999.
19. Jonuleit, H., Kuhn, U., Muller, G., Steinbrink, K., Paragnik, L., Schmitt, E., Knop, J., and Enk, A. H. Proinflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur. J. Immunol., 27: 3135-3142, 1997.
20. + T lymphocytes secreting tumor necrosis factor a in response to HLA-A2.1-binding melanoma and viral peptide antigens. J. Immunol. Methods, 191: 131-142, 1996.
21. Whiteside, T. L., Bryant, J., Day, R., and Herberman, R. B. Natural killer cytotoxicity in the diagnosis of immune dysfunction: criteria for a reproducible assay. J. Clin. Lab. Anal., 4: 102-114, 1990.
22. + T lymphocytes and human squamous cell carcinoma of the head and neck. Cell. Immunol., 177: 35-48, 1997.
23. Reichert, T. E., Rabinowich, H., Johnson, J. T., and Whileside, T. L. Mechanism responsible for signaling and functional defects. J. Immunother., 21: 295-306, 1998.
24. Lang, S., Whiteside, T. L., Lebeau, A., Zeidler, R., Mack, B., and Wollenberg, B. Impairment of T-cell activation in head and neck cancer in situ and in vitro: strategies for an immune restoration. Arch. Otolaryngol. Head Neck Surg., 125: 82-88, 1999.
25. Vora, A. R., Rodgers, S., Parker, A. J., Start, R., Rees, R. C., and Murray, A. K. An immunohistochemical study of altered immunomodulatory molecule expression in head and neck squamous cell carcinoma. Br. J. Cancer, 76: 836-844, 1997.
26. Nestle, F. O., Alijagic, S., Gilliet, M., Yuansheng, S., Grabbe, S., Dummer, R., Burg, G., and Schadendorf, D. Vaccination of melanoma patients with peptide-or tumor lysate-pulsed dendritic cells. Nat. Med., 4: 328-332, 1998.
27. Rosenberg, S. A., Yang, J. C., Schwarzentruber, D. J., Hwu, P., Marincola, F. M., Topalian, S. L., Restifo, N. P., Dudley, M. E., Schwarz, S. L., Spiess, P. J., Wunderlich, J. R., Parkhurst, M. P., Kawakami, Y., Seipp, C. A., Einhorn, J. H., and White, D. E. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nat. Med., 4: 321-327, 1998.
28. Ropke, M., Hald, J., Guldberg, P., Zeuthen, J., Norgaard, L., Fugger, L., Svejgaard, A., van der Burg, S., Nijman, H. W., Melief, C. J. M., and Claesson, M. H. Spontaneous human squamous cell carcinomas are killed by a human cytotoxic T lymphocyte clone recognizing a wild-type p53-derived peptide. Proc. Natl. Acad. Sci. USA, 93: 14704-14707, 1996.
29. Mandruzzato, S., Brasseur, F., Andry, G., Boon, T., and van der Bruggen, P. A CASP-8 mutation recognized by cytolytic T lymphocytes on human head and neck carcinoma. J. Exp. Med., 186: 785-793, 1997.
30. Shichijo, S., Nakao, M., Imai, Y., Takasu, H., Kawamoto, M., Niiya, F., Yang, D., Toh, Y., Yamana, H., and Itoh, K. A gene encoding antigenic peptides of human squamous cell carcinoma recognized by cytotoxic T lymphocytes. J. Exp. Med., 187: 277-288, 1998.
31. Chikamatsu, K., Nakano, K., Storkus, W. J., Appella, E., Lotze, M. T., Whiteside, T. L., and DeLeo, A. B. Generation of anti-p53 cytoloxic T lymphocytes from human peripheral blood using autologous dendritic cells. Clin. Cancer Res., 5: 1281-1288, 1999.
32. Yang, D., Nakao, M., Shichijo, S., Sasatomi, T., Takasu, H., Matsumoto, H., Mori, K., Hayashi, A., Yamana, H., Shirouzu, K., and Itoh, K. Identification of a gene coding for a protein processing shared tumor epitopes capable of inducing HLA-A24-restricted cytotoxic T lymphocytes in cancer patients. Cancer Res., 59: 4056-4063, 1999.
33. Inaba, K., Turley, S., Yamaide, F., Iyoda, T., Mahnke, K., Inaba, M., Pack, M., Subklewe, M., Sauter, B., and Sheff, D. Efficient presentation of phagocytosed cellular fragments on MHC class II products of dendritic cells. J. Exp. Med., 188: 2163-2173, 1998.
34. Labeur, M. S., Roberts, B., Pers, B., Mehling, A., Luger, T. A., Schwarz, T., and Grabbe, S. Generation of tumor immunity by hone marrow-derived dendritic cells correlates with dendritic cell maturation stage. J. Immunol., 162: 168-176, 1999.
35. Rieser, C., Bock, G., Klocker, H., Bartsch, G., and Thurnher, M. Prostaglandin E2 and tumor necrosis factor α cooperate to activate human dendritic cells: synergistic activation of interleukin 12 production. J. Exp. Med., 186: 1603-1608, 1997.
36. Voll, R. E., Herrmann, M., Roth, E., Stach, C., Kalder, J. R., and Girkonlaite, I. Immunosuppressive effects of apoptotic cells. Nature (Lond.), 390: 350-351, 1997.
37. Melcher, A., Todryk, S., Hardwick, N., Ford, M., Jacobson, M., and Vile, R. Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression. Nat. Med., 4: 581-587, 1998.